Effects of hylan on amphotericin-induced carpal lameness in equids.

This research explores the impact of hyaluronan (hylan), a modified form of hyaluronic acid, on lameness induced by amphotericin in horses. Although the hylan treatment did not notably alter the severity of lameness, it provided significant insight into the mechanisms of equine movement and discomfort during lameness.

Study Overview

• This study was conducted as a double-blind experiment, meaning both the researchers and the participating horses’ caretakers did not know which treatment the horse received. This method helps to prevent bias in results.
• The study aimed to assess the efficacy of hylan in treating amphotericin-induced lameness in horses. To establish a baseline, horses were observed trotting on a high-speed treadmill before any treatments were administered.
• Subsequently, lameness was artificially induced in all the horses by administering a preparation of 25 mg of amphotericin B, known for inducing lameness in horses.

Intervention and Pain Management

• After the lameness was induced, the horses were given phenylbutazone and butorphanol tartrate to manage pain and discomfort.
• The horses were then split into four equal groups, each assigned to receive different amounts of hylan (one group with 1 ml, another with 2 ml, third one with 4 ml) or a balanced electrolyte solution (the control group).

Results of the Study

• Over the course of the two-week evaluation period, administering amphotericin B clearly increased lameness in the horses.
• However, the doses of hylan given – regardless of the quantity provided – did not significantly alter the lameness grades.
• The lameness caused noticeable changes in the horses’ movements, including a decrease in the movement of the head and withers (the area between the shoulder blades) during the support phase of the lame forelimb.
• Conversely, there was an increase in the movements of the head and withers during locomotion using the sound, or unimpaired, forelimb.

Summarized Findings

• Despite the apparent potential of hylan, this study shows it did not dramatically change the lameness degree in horses upon administration.
• The research did highlight the significant modification of horse locomotion that occurs as a result of lameness, which is valuable information for potential future therapeutic approaches.